InsidersTradesSigma
Total declarations
Company
▲ Purchases (3 ops.)
▼ Sales (0 ops.)
Explore the full record of transactions filed by François LACOSTE, Directeur Exécutif Recherche & Développement. Director active across 1 companies, notably BIOMERIEUX. Aggregated, 4 disclosures have been published. Total volume traded: €2k. The latest transaction was filed on 1 September 2023 (Attribution gratuite d'actions). Regulator: AMF. All data is accessible without signup.
Declarations4 total
03,250 shares0
ActionHors plateforme de négociation
2023DD926498·
€2,00025.87 shares@ €77.310.0000% mcap100.0% of flow
ActionHors plateforme de négociation
2023DD920724·
Ideal exit: 19 Mar 2024 (T+270)
05,375 shares0
ActionAcquisitions d'actions gratuite
2022DD824955·
Ideal exit: 23 Nov 2022 (T+270)
05,375 shares0
ActionHors plateforme de négociation
2022DD825460·
Ideal exit: 23 Nov 2022 (T+270)
4 of 4 declarations
About François LACOSTE
François Lacoste is the Executive Vice-President of Research & Development at bioMérieux. He leads the company's research and innovation efforts, which specializes in in vitro diagnostics. His role is essential for the development of new diagnostic solutions and for maintaining bioMérieux's leading position in the market.
